Sleep Medicine
Volume 11, Issue 3 , Pages 325-328, March 2010

A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients

  • Ding Zou

      Affiliations

    • Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 31 342 3599; fax: +46 31 825207.
  • ,
  • Ludger Grote

      Affiliations

    • Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
  • ,
  • Derek N. Eder

      Affiliations

    • Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
  • ,
  • Jakub Radlinski

      Affiliations

    • Department of Pathophysiology of Respiratory System, Institute for Tuberculosis and Lung Diseases Rabka-Zdrój Branch, Rabka-Zdrój, Poland
  • ,
  • Jan Hedner

      Affiliations

    • Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden

Received 3 September 2009; received in revised form 13 October 2009; accepted 26 October 2009.

Abstract 

Objective

Pulse wave attenuation, which occurs in association with obstructive sleep apnea (OSA), is sympathetically mediated. We compared the effect of Doxazosin (DO, a peripheral α-receptor inhibitor) and Enalapril (EN, an ACE inhibitor) on digital vasoconstriction and nocturnal blood pressure (BP) in hypertensive OSA patients.

Methods

A double-blind, crossover study comparing equipotent dosages of DO (4mg/day for 2weeks with 8mg/day for an additional 2weeks) and EN (10mg/day and 20mg/day, respectively) was undertaken in 16 male OSA patients (age 55±7years, body mass index 30.1±3.8kg/m2) with hypertension. Assessments including ambulatory 24-h BP, full-night polysomnography with simultaneous peripheral arterial tone (PAT) and beat-to-beat finger BP monitoring (Finapres) were made at the end of each treatment period. Nighttime BP and digital vasoconstrictions associated with apneic events (measured as the ratio of PAT amplitudes during and after apneas) were analyzed.

Results

There were no differences between the two treatments in the 24-h BP profile and OSA severity. But the nighttime average beat-to-beat finger BP was significantly higher under DO treatment (systolic BP 129±13 vs. 119±23mm Hg, P=0.02; diastolic BP 81±12 vs. 74±14mm Hg, P=0.04, DO and EN respectively). In a linear mixed effects regression model, the PAT ratio during apnea increased 5.3% under DO compared with EN (P<0.0001). Each percentage decrease of apneic related oxygen desaturation was associated with 0.9% decrease in the PAT ratio (P<0.0001). REM sleep was associated with 2.2% decrease of PAT ratio compared to NREM sleep (P=0.002).

Conclusion

Digital vasoconstrictions associated with apneic events are α-receptor mediated. DO compared to EN has a proportionally poor effect on nocturnal BP control in OSA patients, which may be due to the enhanced sympathetic nervous system activity characteristic of this condition.

Keywords: Antihypertensive treatment, Autonomic nervous system, Blood pressure, Obstructive sleep apnea, Peripheral arterial tone, Pulse wave attenuation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1389-9457(10)00067-5

doi:10.1016/j.sleep.2009.10.004

Sleep Medicine
Volume 11, Issue 3 , Pages 325-328, March 2010